Stay updated on ENLIVEN Trial Assessing BIO89-100 in NASH

Sign up to get notified when there's something new on the ENLIVEN Trial Assessing BIO89-100 in NASH page.
Latest website image capture
Clouds background image

Latest updates to the ENLIVEN Trial Assessing BIO89-100 in NASH page

  1. Check
    today
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-18T13:28:29.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Added a platform revision entry v3.5.0 and removed the previous revision v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-28T01:29:21.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 on the site.
    Difference
    0.0%
    Check dated 2026-03-06T18:01:58.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed Revision: v3.4.1.
    Difference
    0.0%
    Check dated 2026-02-13T12:22:32.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1. No substantive changes to the study details, eligibility criteria, outcomes, or locations are evident. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T09:18:07.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    The page now displays the actual 'Results First Posted' and 'Last Update Posted' dates, replacing the previously shown 'Estimated' versions. This clarifies when results were published and updated.
    Difference
    0.1%
    Check dated 2026-01-22T10:22:51.000Z thumbnail image

Stay in the know with updates to ENLIVEN Trial Assessing BIO89-100 in NASH

Enter your email address, and we'll notify you when there's something new on the ENLIVEN Trial Assessing BIO89-100 in NASH page.